To assess the severity of dry eye disease in patients with blepharospasm (BEB) before (control) and after injection of botulinum neurotoxin A (BoNT/A).
Latest Information Update: 13 Dec 2021
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm
- Focus Therapeutic Use
- 13 Dec 2021 New trial record
- 01 Dec 2021 Results published in the Journal Francais d'Ophtalmologie